DrugPatentWatch Database Preview
Patent: 10,030,051
Summary for Patent: 10,030,051
| Title: | Antibody targeting through a modular recognition domain |
| Abstract: | The present invention provides antibodies containing one or more modular recognition domains (MRDs) for targeting the antibodies to specific sites. The use of the antibodies containing one or more modular recognition domains to treat disease, and methods of making antibodies containing one or more modular recognition domains are also provided in the invention. |
| Inventor(s): | Barbas, III; Carlos F. (La Jolla, CA) |
| Assignee: | The Scripps Research Institute (La Jolla, CA) |
| Application Number: | 14/963,722 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,030,051
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | HERCEPTIN HYLECTA | trastuzumab; hyaluronidase-oysk | INJECTABLE;SUBCUTANEOUS | 761106 | 2019-02-28 | ⤷ Try it Free | The Scripps Research Institute (La Jolla, CA) | 2028-01-03 | RX | search | |
| Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 1998-09-25 | ⤷ Try it Free | The Scripps Research Institute (La Jolla, CA) | 2028-01-03 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,030,051
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201004730 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 2009088805 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 2012009705 | ⤷ Try it Free |
| United States of America | 10087222 | ⤷ Try it Free |
| United States of America | 2011189206 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
